Evidence map›Paper›PMID 36001622›Full record

ArticlePloS one2022

Creation of a Global Vaccine Risk Index.

Tasmiah Nuzhath, Peter J Hotez, Ashish Damania, P Shuling Liu, Brian Colwell

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Tasmiah NuzhathDepartment of Health Behavior, Texas A&M School of Public Health, College Station, Texas, United States of America.ORCID 0000-0003-2893-5441
Peter J HotezHagler Institute for Advanced Study at Texas A&M University, College Station, Texas, United States of America.
Ashish DamaniaM.D. Anderson Cancer Center, Houston, Texas, United States of America.
P Shuling LiuStatistical Collaboration Center, Department of Statistics, Texas A&M University, College Station, Texas, United States of America.
Brian ColwellDepartment of Health Behavior, Texas A&M School of Public Health, College Station, Texas, United States of America.ORCID 0000-0002-9338-2778
Texas A&M Health Science Center · USBaylor University · USTexas A&M University · USThe University of Texas MD Anderson Cancer Center · US

Funding

Wellcome Trust
6 · The paper itself

Abstract

The World Health Organization has identified vaccine hesitancy as one of its top ten global health threats for 2019. Efforts are underway to define the factors responsible for reductions in vaccine confidence. However, as global measles cases accelerated beginning in 2018, it became evident that additional factors were promoting measles re-emergence, including war, political and socio-economic collapse, shifting poverty, and vulnerability to weather events and climate change. Accordingly, we propose a Global Vaccine Risk Index (VRI) to consider these variables as a more comprehensive means to identify vulnerable nations where we might expect measles and other vaccine-preventable diseases to emerge or re-emerge. In Sub-Saharan African and Middle Eastern nations, conflict and political instability predominated as the basis for high vaccine risk scores, whereas in Southeast Asian countries, the major reasons included climate variability, current levels of measles vaccination coverage, and economic and educational disparities. In Europe, low vaccine confidence and refugee movements predominated, while in the Americas, economic disparities and vaccine confidence were important. The VRI may serve as a useful indicator and predictor for international agencies committed to childhood immunizations and might find relevance for accelerating future COVID19 vaccination programs.

Indexed as

COVID-19MeaslesVaccinesChildCOVID-19 VaccinesGlobal HealthHumansMeasles VaccineVaccinationVaccination CoverageCOVID-19 VaccinesMeasles VaccineVaccines

Identifiers

PMID36001622
PMCPMC9401103
OpenAlexW4293102911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.